Error loading player: No playable sources found
AM23-MN-20-O
AM23-MN-20-O: Oral Abstract - Practical Immunohematology (Enduring)
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
Oral abstract session featuring the latest research on Practical Immonuhematology
Learning Objectives
- Evaluate RBC antigen typing discrepancies between micro-array molecular method and serologic antigen typing confirmation.
- Detail an investigational reagent capable of effectively and successfully neutralizing therapeutic anti-CD47 interference in patient pretransfusion testing.
- Demonstrate an updated flow cytometry assay for the quantitation of erythrocyte D antigen sites.
- Describe the first 25 years of the American Rare Donor Program, including the growth in rare donors in the program, the growth in requests for rare blood products, and the ability of the program to fill requests.
Speakers
Chloe Hutchison, BS
National Institutes of Health, Clinical Center, Department of Transfusion Medicine
Margaret A. Keller, PhD
Executive, National Laboratories, American Red Cross
Lisa Scott, MT, SBB, MBA
Mayo Clinic
Randall Velliquette, SBB
New York Blood Center Enterprises
Moderators
Jeremy Jacobs, MD, MHS
Special Coagulation Fellow, Department of Laboratory Medicine, Yale School of Medicine
Robert Maitta, MD, PhD
University Hospitals Cleveland Medical Center
Tracks
Related Products
AM24-SN-08-O: The Changing Landscape of Managing a Rare Blood Frozen Inventory (Enduring)
Currently there are only two options for processing frozen red cell units and washed units on a licensed device. One of these two instruments are used in blood centers throughout the US that freeze red blood cell units and wash products…
AM23-TU-12-O: Oral Abstract - Novel Alleles (Enduring)
Oral abstract session featuring the latest research on Novel Alleles
AM23-MN-03-O: Hyperhemolysis Syndrome: Recognition and Current Management Strategies of a Potentially Fatal Transfusion Complication (Enduring)
Hyperhemolysis syndrome (HHS) is an uncommon but life-threatening complication of transfusion that classically occurs in patients with sickle cell anemia but may also be seen in patients without hemoglobinopathies. Recognition of HHS is critical for appropriate management but can be challenging…
